Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute myeloid leukemia”
SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT05445154. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Pharmacokinetics of Intravenous and Oral APX001 in Patients With Acute Myeloid Leukemia (AML) and Neutropenia
ClinicalTrials.gov study NCT03333005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Targeting Acute Myeloid Leukemia Immunosuppressive Microenvironment by combinedIDO1 Inhibition and PD-1 Blockade
ClinicalTrials.gov study NCT06874257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine in Combination With Mitoxantrone, Etoposide Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01249430. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT02587871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission
ClinicalTrials.gov study NCT00963521. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT07223814. IPD Sharing: YES. Countries: 0. Publications: 0.
Evaluate Efficacy and Safety/Tolerability Profiles of Antroquinonol in Acute Myeloid Leukemia (AML) Adult Patients
ClinicalTrials.gov study NCT03823352. IPD Sharing: NO. Countries: 1. Publications: 0.
IA14 Induction in Young Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04069208. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dendritic Cell Vaccination for Patients With Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT00834002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00002945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00898092. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05426798. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Single-Center Phase 1 Study With Escalating Doses of Tocilizumab in Combination With Venetoclax and Azacitidine Chemotherapy in Patients With Acute Myeloid Leukemia (AML). TOCIVENA
ClinicalTrials.gov study NCT07392814. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05520567. IPD Sharing: YES. Countries: 1. Publications: 0.
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Sy
ClinicalTrials.gov study NCT00801489. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation
ClinicalTrials.gov study NCT00809250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ASTX660 as a Single Agent and in Combination With ASTX727 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT04155580. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06001788. IPD Sharing: UNDECIDED. Countries: 3. Publications: 0.
DEC-205/NY-ESO-1 Fusion Protein CDX-1401and Decitabine in Treating Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01834248. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.